Daily BriefsJapan

Daily Brief Japan: Hamee Corp, Tokyo Electron, Kohsoku Corp, Chugoku Marine Paints, Shinmaywa Industries, Kanematsu Corp, TSE Tokyo Price Index TOPIX, H2O Retailing, Financial Products Group Co, Jcr Pharmaceuticals and more

In today’s briefing:

  • Buy Hamee Corp
  • Tokyo Electron (8035 JP): Q1 FY03/26 flash update
  • Kohsoku Corp (7504 JP): Q1 FY03/26 flash update
  • Chugoku Marine Paints (4617 JP): Q1 FY03/26 flash update
  • Shinmaywa Industries (7224 JP): Q1 FY03/26 flash update
  • Kanematsu Corp (8020 JP): Q1 FY03/26 flash update
  • Amid Declining Birth Rates and Working-Age Populations, Japan Still Hesitates to Embrace Diversity
  • H2O Retailing (8242 JP): Q1 FY03/26 flash update
  • Financial Products Group Co (7148 JP): Q3 FY09/25 flash update
  • JCR Pharma (4552 JP): Izcargo Holds Revenue As Price Revision Impacts Growject; Guidance Reiterated


Buy Hamee Corp

By Richard Howe

  • Some of my favorite situations are international spin-offs because they fly under the radar. Hamee has not been written up on VIC, Seeking Alpha or Twitter (I found one writeup on Substack).
  • The company is 3 months away from breaking up into two separate companies which both look attractive. It is currently classified as a Specialty Retail company but will spin off a high growth, high margin, SaaS company in November that I estimate is worth more than the entire company’s market cap today.
  • The stock looks compelling on an absolute basis (5.1x NTM EBITDA) and SOTP basis. I see 31% to 117% upside over the next 6 months as the break up is completed.

Tokyo Electron (8035 JP): Q1 FY03/26 flash update

By Shared Research

  • In Q1 FY03/26, the company reported revenue of JPY549.6bn, operating profit of JPY144.7bn, and net income of JPY117.8bn.
  • The revised FY03/26 forecast projects revenue of JPY2.35tn, operating profit of JPY570.0bn, and net income of JPY444.0bn.
  • The company plans aggressive R&D investments, increasing from JPY250.0bn in FY03/25 to JPY295.0bn in FY03/26.

Kohsoku Corp (7504 JP): Q1 FY03/26 flash update

By Shared Research

  • Revenue increased by 14.0% YoY to JPY30.6bn, with operating profit up 16.1% YoY to JPY1.1bn.
  • Core product revenue grew: food product containers by 19.8% YoY, films and laminates by 11.4% YoY.
  • Gross profit reached JPY6.1bn (+15.9% YoY), with SG&A expenses totaling JPY5.0bn (+15.9% YoY).

Chugoku Marine Paints (4617 JP): Q1 FY03/26 flash update

By Shared Research

  • In Q1 FY03/26, sales increased by 12.1% YoY, driven by marine and industrial paints, despite container paint declines.
  • Operating profit rose 16.5% YoY to JPY3.9bn, aided by optimized selling prices and high-value-added product sales.
  • Net income fell 48.9% YoY due to absence of prior extraordinary gains, despite improved gross profit margin.

Shinmaywa Industries (7224 JP): Q1 FY03/26 flash update

By Shared Research

  • Orders increased by 2.5% YoY to JPY74.3bn, while revenue rose by 0.4% YoY to JPY57.7bn.
  • The Special Purpose Truck business saw a 26.2% YoY rise in orders to JPY42.9bn, with revenue up 4.2%.
  • The company revised its FY03/26 forecast, expecting orders of JPY320.0bn and revenue of JPY285.0bn, despite weaker EV demand.

Kanematsu Corp (8020 JP): Q1 FY03/26 flash update

By Shared Research

  • Companywide revenue remained flat YoY at JPY251.1bn, while operating profit decreased by 9.6% YoY to JPY10.6bn.
  • ICT Solution segment revenue rose 23.7% YoY, with operating profit increasing 64.0% YoY to JPY2.3bn.
  • Aerospace and motor vehicles business saw revenue decline by 16.6% YoY, with a 21.2% YoY drop in operating profit.

Amid Declining Birth Rates and Working-Age Populations, Japan Still Hesitates to Embrace Diversity

By Aki Matsumoto

  • Since the government hasn’t taken any actions, the birth rate has dropped much lower than expected, and the population is shrinking much faster than predicted.
  • There are various reasons why more people are choosing not to marry. It is necessary to implement policies that meet the needs of people with diverse views.
  • With the decline in working-age population, it is necessary to incorporate as many diverse people as possible into human capital to maximize the abilities of as many people as possible.

H2O Retailing (8242 JP): Q1 FY03/26 flash update

By Shared Research

  • In Q1 FY03/26, Department Store business operating profit fell 56.6% YoY due to lower gross profit and higher SG&A expenses.
  • Supermarket business operating profit increased 35.7% YoY, driven by higher gross profit from sales growth and new store formats.
  • Shopping Center business sales fell 8.5% YoY, impacted by subsidiary divestitures and ongoing guest room renovations at Ours Inn Hankyu.

Financial Products Group Co (7148 JP): Q3 FY09/25 flash update

By Shared Research

  • Revenues reached JPY90.6bn (+11.5% YoY), driven by record-high sales in Domestic Real Estate Fund Business.
  • Operating profit was JPY19.2bn (-16.5% YoY), with a gross profit margin of 30.0% (-7.5pp YoY).
  • Non-operating income increased to JPY2.6bn (+17.2% YoY), while non-operating expenses decreased to JPY1.7bn (-7.3% YoY).

JCR Pharma (4552 JP): Izcargo Holds Revenue As Price Revision Impacts Growject; Guidance Reiterated

By Tina Banerjee

  • Jcr Pharmaceuticals (4552 JP) revenue increased 5% to ¥8.6B in Q1FY26, mainly driven by Izcargo, marred to an extent by NHI price revision impact on Growject.
  • Higher SG&A expenses (up 9%) on increased commission payments and increased R&D expenses (up 5% as clinical development activities progressed) resulted in operating loss of ¥606M.
  • JCR’s two pipeline drugs are under Phase III trials: pabinafusp alfa (JR-141) for Hunter syndrome and JR-142, for growth hormone deficiency. Approvals not expected before late FY27 or FY28.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars